1. Home
  2. CGEM vs CNDT Comparison

CGEM vs CNDT Comparison

Compare CGEM & CNDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • CNDT
  • Stock Information
  • Founded
  • CGEM 2016
  • CNDT 2016
  • Country
  • CGEM United States
  • CNDT United States
  • Employees
  • CGEM N/A
  • CNDT N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • CNDT Business Services
  • Sector
  • CGEM Health Care
  • CNDT Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • CNDT Nasdaq
  • Market Cap
  • CGEM 730.2M
  • CNDT 628.4M
  • IPO Year
  • CGEM 2021
  • CNDT N/A
  • Fundamental
  • Price
  • CGEM $8.46
  • CNDT $3.61
  • Analyst Decision
  • CGEM Strong Buy
  • CNDT Buy
  • Analyst Count
  • CGEM 7
  • CNDT 1
  • Target Price
  • CGEM $32.50
  • CNDT $9.00
  • AVG Volume (30 Days)
  • CGEM 420.6K
  • CNDT 985.5K
  • Earning Date
  • CGEM 03-13-2025
  • CNDT 02-12-2025
  • Dividend Yield
  • CGEM N/A
  • CNDT N/A
  • EPS Growth
  • CGEM N/A
  • CNDT N/A
  • EPS
  • CGEM N/A
  • CNDT 2.23
  • Revenue
  • CGEM N/A
  • CNDT $3,356,000,000.00
  • Revenue This Year
  • CGEM N/A
  • CNDT N/A
  • Revenue Next Year
  • CGEM N/A
  • CNDT $2.19
  • P/E Ratio
  • CGEM N/A
  • CNDT $1.65
  • Revenue Growth
  • CGEM N/A
  • CNDT N/A
  • 52 Week Low
  • CGEM $8.36
  • CNDT $2.96
  • 52 Week High
  • CGEM $30.19
  • CNDT $4.90
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 27.85
  • CNDT 37.93
  • Support Level
  • CGEM $8.35
  • CNDT $3.62
  • Resistance Level
  • CGEM $9.51
  • CNDT $4.26
  • Average True Range (ATR)
  • CGEM 0.46
  • CNDT 0.24
  • MACD
  • CGEM -0.08
  • CNDT -0.06
  • Stochastic Oscillator
  • CGEM 11.91
  • CNDT 6.64

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.

Share on Social Networks: